Theraclone Sciences announces identification of new vulnerable site on HIV using antibodies discovered with Theraclone technology

25-04-2014 Business Wire HealthComments (0)

Antibiotics and Infectious diseasesPharmaceuticalTheraclone SciencesUSA

Theraclone published of data in the May issue of Immunity regarding antibodies with significant potency and breadth against human immunodeficiency virus (HIV).

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top